Azithromycin Prices Trend and Forecast

North America

Azithromycin Price displayed stable market dynamics throughout the first quarter of 2023. With the start of Q1 2023, prices were recorded to increase stably, supported by sustained purchases from the pharmaceutical end-user industry and merchant stocks to meet demand. Also, the ease of trade disruption supported the Azithromycin market trend. With an average quarterly inclination of 0.40%, the settlement price of Azithromycin API was recorded at USD 103750/MT CFR Houston. Enough inventories among the merchants and the domestic suppliers kept the market situation firm. With stable production costs and ease in demand, trading activities were also feeble, keeping the market Weak.

Asia

Azithromycin prices witnessed a positive trajectory in the APAC region in the first quarter of 2023. At the commencement of Q1 2023, the prices recorded to drop backed by sufficient inventories and a stable demand outlook. Later with the onset of February, After the Lunar New Year break, the Chinese pharmaceutical markets technically returned on a positive note with an increase in orders and shipments from both the domestic and the international market. As the market was reopened, factory and port operations resumed. Also, with the soaring offtake and increase in the no. of international orders, Azithromycin prices increased in the Chinese market. At the termination of Q1 202, the settlement price of Azithromycin API was accessed at USD 101340/MT FOB Shanghai with an average quarterly inclination of 1.33%.

Europe

The first quarter of 2023 saw stable market dynamics for Azithromycin. Prices started to rise steadily at the beginning of Q1 2023, helped by ongoing purchases from the pharmaceutical end-user business and merchant stockpiles to fulfill demand. The settlement price for azithromycin API was recorded at USD 105560/MT CFR Houston, with an average quarterly inclination of 0.54%. The market position remained stable thanks to sufficient stockpiles held by retailers and domestic suppliers. The market remained weak due to stable manufacturing costs, easy demand, and weak trade activity. Also, the reduced energy prices further lower doe the production cost keeping the market weak.

ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst's primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.